Integra LifeSciences Recalls Products From Boston Facility, Takes Financial Hit
Executive Summary
After consulting with the US FDA, Integra Life Sciences initiated a recall of products produced in its Boston Facility. The company expects losses of $22m.
You may also be interested in...
Class I Recall For Integra’s CereLink Intracranial Pressure Monitors
The US FDA has labelled a June recall of intracranial pressure monitors from Integra with its most serious designation, class I.
News We’re Watching: Two Join Illumina Board, FDA Plans Health Equity Meeting, Pre-Eclampsia Test Cleared
This week, Illumina’s board added two independent members; the VA and the FDA agreed to collaborate on supply chain issues; and Think Surgical, Thermo Fisher Scientific and Blue Earth all landed FDA clearances.
AdvaMed Offers Plan To Strengthen Medtech Supply Chain
Medtech trade group AdvaMed is offering a list of recommendations to beef up the nation’s medical technology supply chain. Public-private partnerships are central to the group’s plan.